ABN AMRO Bank’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.07M Sell
37,023
-7,538
-17% -$1.76M 0.1% 96
2025
Q4
$9.18M Buy
44,561
+1,882
+4% +$372K 0.09% 99
2025
Q3
$7.8M Buy
42,679
+40,274
+1,675% +$6.9M 0.08% 100
2025
Q2
$369K Sell
2,405
-931
-28% -$143K ﹤0.01% 147
2025
Q1
$553K Buy
3,336
+1,018
+44% +$159K 0.01% 141
2024
Q4
$332K Sell
2,318
-16
-0.7% -$2.48K ﹤0.01% 154
2024
Q3
$376K Buy
2,334
+16
+0.7% +$2.55K 0.01% 145
2024
Q2
$342K Sell
2,318
-200
-8% -$29.7K 0.01% 141
2024
Q1
$398K Sell
2,518
-2,859
-53% -$455K 0.01% 136
2023
Q4
$847K Buy
5,377
+640
+14% +$98.1K 0.01% 123
2023
Q3
$739K Buy
4,737
+253
+6% +$41.7K 0.01% 117
2023
Q2
$742K Buy
4,484
+713
+19% +$115K 0.02% 113
2023
Q1
$586K Buy
+3,771
New +$609K 0.01% 118

Other funds holding JNJ

ABN AMRO Bank's JNJ Position: Q1 2026 in Review

ABN AMRO Bank reduced its Johnson & Johnson (JNJ) stake by 17% in Q1 2026, selling an estimated $1.76M and leaving 37,023 shares worth $9.07M. The position accounts for 0.1% of the portfolio, ranked #96.

ABN AMRO Bank first reported a position in JNJ in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.18M in Q4 2025. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • ABN AMRO Bank held 37,023 shares of Johnson & Johnson worth $9.07M as of Q1 2026.
  • ABN AMRO Bank sold 7,538 Johnson & Johnson shares in Q1 2026, an estimated $1.76M.
  • Johnson & Johnson made up 0.1% of ABN AMRO Bank's portfolio in Q1 2026, its #96 holding.
  • ABN AMRO Bank first reported a position in Johnson & Johnson in Q1 2023 and has held it in 13 quarters since.
  • ABN AMRO Bank's Johnson & Johnson position peaked at $9.18M in Q4 2025.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on ABN AMRO Bank's 13F filing for Q1 2026, filed 22 Apr 2026.